Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
1,099
Value
$27.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ACAD by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,099$27.8K<0.1%+942+600.0%AddedHolders
Q1 2026157$3.50K<0.1%−72−31.4%ReducedHolders
Q4 2025229$6.12K<0.1%00.0%UnchangedHolders
Q3 2025229$4.89K<0.1%−16−6.5%ReducedHolders
Q2 2025245$5.29K<0.1%−32,469−99.3%ReducedHolders
Q1 202532,714$543.4K<0.1%−144−0.4%ReducedHolders
Q4 202432,858$602.9K<0.1%−76−0.2%ReducedHolders
Q3 202432,934$506.5K<0.1%+31,426+2,084.0%AddedHolders
Q2 20241,508$24.5K<0.1%+848+128.5%AddedHolders
Q1 2024660$12.2K<0.1%−1−0.2%ReducedHolders
Q4 2023661$20.7K<0.1%−43−6.1%ReducedHolders
Q3 2023704$14.7K<0.1%−1−0.1%ReducedHolders
Q2 2023705$16.9K<0.1%−605−46.2%ReducedHolders
Q1 20231,310$24.7K<0.1%+299+29.6%AddedHolders
Q4 20221,011$16.1K<0.1%−216−17.6%ReducedHolders
Q3 20221,227$20.0K<0.1%−314−20.4%ReducedHolders
Q2 20221,541$22.0K<0.1%−1,481−49.0%ReducedHolders
Q1 20223,022$73.0K<0.1%+575+23.5%AddedHolders
Q4 20212,447$57.0K<0.1%−1,691−40.9%ReducedHolders
Q3 20214,138$69.0K<0.1%−415−9.1%ReducedHolders
Q2 20214,553$111.0K<0.1%+569+14.3%AddedHolders
Q1 20213,984$103.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.